Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
J Gen Intern Med
.
2020 Jun;35(6):1928-1930.
doi: 10.1007/s11606-019-05432-6.
Epub 2019 Oct 17.
Authors
Aishwarya Vijay
1
,
Ravi Gupta
2
,
Patrick Liu
1
,
Sanket S Dhruva
3
4
,
Nilay D Shah
5
6
,
Joseph S Ross
7
8
9
Affiliations
1
Yale University School of Medicine, New Haven, CT, USA.
2
Department of Medicine, Johns Hopkins Hospital, Johns Hopkins School of Medicine, Baltimore, MD, USA.
3
San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
4
San Francisco School of Medicine, University of California, San Francisco, CA, USA.
5
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
6
Division of Health Care Policy and Research, Mayo Clinic, Rochester, MN, USA.
7
Center for Outcomes Research and Evaluation, Yale-New Haven Health System, New Haven, CT, USA. joseph.ross@yale.edu.
8
Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. joseph.ross@yale.edu.
9
Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA. joseph.ross@yale.edu.
PMID:
31625043
PMCID:
PMC7280368
DOI:
10.1007/s11606-019-05432-6
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Aged
Drugs, Generic
Humans
Medicare Part D*
Prescription Drugs*
United States
Substances
Drugs, Generic
Prescription Drugs
Grants and funding
U01 FD004585/FD/FDA HHS/United States
R03 HS025517/HS/AHRQ HHS/United States
R56 HL130496/HL/NHLBI NIH HHS/United States
UL1 TR001863/TR/NCATS NIH HHS/United States
R01 HS025164/HS/AHRQ HHS/United States
R01 HS025402/HS/AHRQ HHS/United States
R01 HS022882/HS/AHRQ HHS/United States
R01 HL131535/HL/NHLBI NIH HHS/United States
U01 FD005938/FD/FDA HHS/United States